New Jersey · 2026-2027 Regular Session · Bill

A 2020: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient.

In committee Last action January 13, 2026: Introduced, Referred to Assembly Health Committee

Plain-language summary

A 2020 is a bill introduced in the New Jersey House on January 13, 2026. According to its official title, it concerns: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient. Primary sponsor: Shama Haider (Democratic). Most recent recorded action (January 13, 2026): Introduced, Referred to Assembly Health Committee.

Sponsors

Primary sponsor: Shama Haider (Democratic).